Our Objective is Simple

In an increasingly competitive market environment, Apotex continually strives to introduce quality, affordable medicines to consumers. Apotex has 600 different products under development globally, which include generics, innovative molecules, and biotechnology products, allowing us to serve different segments of the industry and reach a broad range of both customers and consumers. We have the capacity to produce up to 20 billion tablets and capsules per year, and manufacture a full range of dosage forms, including tablets, capsules, oral suspensions, ophthalmic, nasals, and a full range of liquid injectable products.